U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935642) titled 'BERBERINE SUPPLEMENTATIONS' on Nov. 02.
Brief Summary: This randomized, placebo-controlled interventional study aims to evaluate the effects of 60 days of supplementation with a liposomal Berberis vulgaris-based product on antioxidant status, selected biochemical parameters, body weight, body mass index (BMI), and body composition in healthy adult volunteers. The planned total enrollment is 40 participants. The intervention group will receive one 200 mg capsule daily for 60 days, subject to confirmation of the product's composition and labeling. The comparator group will receive a placebo according to the approved study protocol. To...